Drug delivery partnering terms and agreements

  • 58 views
Uploaded on

The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds …

The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
58
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Drug Delivery Partnering Terms and Agreements The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding andunprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leadinghealthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug deliverypartnering deals. The majority of deals are discovery or development stage whereby the licensee obtains aright or an option right to license the licensors drug delivery technology. These deals tend to bemulticomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insightinto the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilstmany smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms ofhow payments are triggered – contract documents provide this insight where press releases do not. This report contains over 2,000 links to online copies of actual drug delivery deals and contract documents assubmitted to the Securities Exchange Commission by companies and their partners. Contract documentsprovide the answers to numerous questions about a prospective partner’s flexibility on a wide range ofimportant issues, many of which will have a significant impact on each party’s ability to derive valuefrom the deal. The initial chapters of this report provide an orientation of drug delivery dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst Chapter 2 provides an overview of the trends in drug delivery dealmaking since 2007, including details ofaverage headline, upfront, milestone and royalty terms. Chapter 3 provides a review of the leading drug delivery deals since 2007. Deals are listed by headline value,signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal hasan agreement contract published at the SEC a link provides online access to the contract. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summaryfollowed by a comprehensive listing of drug delivery deals as well as contract documents available in thepublic domain. Where available, each deal title links via Weblink to an online version of the actual contractdocument, providing easy access to each contract document on demand. Chapter 5 provides a comprehensive and detailed review of drug delivery partnering deals signed andannounced since 2007, where a contract document is available in the public domain. The chapter is organizedby company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensingetc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record andthe contract document, providing easy access to each contract document on demand. Chapter 6 provides a comprehensive and detailed review of drug delivery partnering deals organized byspecific drug delivery technology type. Each deal title links via Weblink to an online version of the deal recordand where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in drug deliveryDrug Delivery Partnering Terms and Agreements
  • 2. partnering and dealmaking since 2007. In addition, a comprehensive appendix is provided organized by drug delivery partnering company A-Z, dealtype definitions and drug delivery partnering agreements example. Each deal title links via Weblink to anonline version of the deal record and where available, the contract document, providing easy access to eachcontract document on demand. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in theresearch, development and commercialization of drug delivery technologies and products. Drug Delivery Partnering Terms and Agreements is intended to provide the reader with an in-depthunderstanding and access to drug delivery trends and structure of deals entered into by leading companiesworldwide. Drug Delivery Partnering Terms and Agreements includes: Trends in drug delivery dealmaking in the biopharma industry since 2007 Analysis of drug delivery dealstructure Access to headline, upfront, milestone and royalty data Case studies of real-life drug delivery dealsAccess to over 2,000 drug delivery contract documents The leading drug delivery deals by value since 2007Most active drug delivery dealmakers since 2007 The leading drug delivery partnering resources In DrugDelivery Partnering Terms and Agreements, the available contracts are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific therapy target Each deal title links via Weblink to an online version of the deal record and where available, the contractdocument, providing easy access to each contract document on demand. Benefits: In-depth understanding of drug delivery deal trends since 2007 Access to headline, upfront, milestone androyalty data Analysis of the structure of drug delivery agreements with numerous real life case studiesComprehensive access to over 2,000 actual drug delivery contracts entered into by the world’sbiopharma companies Detailed access to actual drug delivery contracts enter into by the leading fiftybigpharma companies Insight into the terms included in a drug delivery agreement, together with real worldclause examples Understand the key deal terms companies have agreed in previous deals Undertaketable Of Contentexecutive Summarychapter 1 – Introductionchapter 2 – Trends In Drug Delivery Dealmaking2.1. Introduction2.2. Drug Delivery Partnering Over The Years2.3. Bigpharma Drug Delivery Dealmaking Activity2.4. Drug Delivery Partnering By Deal Type2.5. Drug Delivery Partnering By Disease Type2.6. Partnering By Drug Delivery Technology TypeDrug Delivery Partnering Terms and Agreements
  • 3. 2.7. Average Deal Terms For Drug Delivery Partnering2.7.1 Drug Delivery Headline Values2.7.2 Drug Delivery Upfront Payments2.7.3 Drug Delivery Milestone Payments2.7.4 Drug Delivery Royalty Rates2.8. The Anatomy Of Drug Delivery Partnering2.9. Drug Delivery Or Specialty Pharma?2.9.1. Is Specialty Pharma The Only Way For Drug Delivery?2.9.2. Best Practice For Optimizing Drug Delivery Program Development2.9.3. The Anatomy Of A Drug Delivery Deal2.9.3.a. Case Study 1: Alpharma – Durect2.3.3.b. Case Study 2: Bayer – Mdrna2.3.3.c. Case Study 3: Aradigm – Lung Rxchapter 3 – Leading Drug Delivery Deals3.1. Introduction3.2. Top Drug Delivery Deals By Valuechapter 4 – Bigpharma Drug Delivery Deals4.1. Introduction4.2. How To Use Bigpharma Drug Delivery Partnering Deals4.3. Bigpharma Drug Delivery Partnering Company Profilesabbottactavisactelionallerganamgenaspen Pharmacareastellasastrazenecabaxter Internationalbayerbiogen Idecboehringer Ingelheimbristol-myers Squibbcelgenecsldaiichi Sankyodainippon Sumitomoeisaieli Lillyendo Pharmaceuticalsforest LaboratoriesDrug Delivery Partnering Terms and Agreements
  • 4. galdermagilead Sciencesglaxosmithklinegrifolshospirajohnson & Johnsonkyowa Hakko Kirinlundbeckmenarinimerck & Comerck Kgaamitsubishi Tanabenovartisnovo Nordiskotsukapfizerpurduerochesanofiserviershionogishiretakedatevawarner Chilcottwatsonchapter 5 – Drug Delivery Partnering Contracts Directory5.1. Introduction5.2. Company A-z5.3. By Deal Typeasset Purchaseassignmentbigpharma Outlicensingco-developmentcollaborative R&dco-marketcontract Serviceco-promotioncradadevelopmentdistributionDrug Delivery Partnering Terms and Agreements
  • 5. equity Purchaseevaluationgrantjoint Venturelicensinglitigationloanmanufacturingmarketingmaterial Transferoptionpromotionresearchroyalty Financingsettlementspin Outsub-licensesupplytechnology Transferterminationwarranty5.4. By Stage Of Developmentdiscoverypreclinicalphase Iphase Iiphase Iiiregulatorymarketedformulation5.5. By Therapy Areaanaestheticscardiovascularcentral Nervous Systemdermatologygastrointestinalgenetic Disordersgenitourinarygynaecologyhematologyhospital CareimmunologyinfectivesDrug Delivery Partnering Terms and Agreements
  • 6. metabolicmusculoskeletaloncologyophthalmicspediatricsrespiratorychapter 6 – Drug Delivery Dealmaking By Technology Type6.1. Introduction6.2. Deals By Drug Delivery Typedrug Deliverybioavailabilityimplantableoral Deliverydelayed Releaserapid Releaseparenteralinfusioninjectablepro-drugtargetedtopicaltransdermaltransmucosalbuccalinhalednasalocularrectalsublingualurogenitalabout Wildwood Venturescurrent Partneringcurrent Agreementscurrent Reportsrecent Titles From Currentpartneringappendicesintroductionappendix 1 – Directory Of Drug Delivery Deals By Company A-z 2007-2012appendix 2 – Directory Of Drug Delivery Deals By Stage Of Development 2007-2012Drug Delivery Partnering Terms and Agreements
  • 7. appendix 3 – Directory Of Drug Delivery Deals By Deal Type 2007-2012appendix 4 – Directory Of Drug Delivery Deals By Therapy Area 2007-2012appendix 5 – Drug Delivery Partnering Resource Center online Drug Delivery Partnering DrugDelivery Partnering Events further Reading On Drug Delivery DealmakingAbout Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.researchmoz.us/Drug Delivery Partnering Terms and Agreements